Ginsberg, Henry N.

Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism

Reyes-Soffer, G., Sztalryd, C., Horenstein, R. B., Holleran, S., Matveyenko, A., Thomas, T., Nandakumar, R., Ngai, C., Karmally, W., Ginsberg, H. N., et al. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 97

CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects

Thomas, T., Zhou, H., Karmally, W., Ramakrishnan, R., Holleran, S., Liu, Y., Jumes, P., Wagner, J. A., Hubbard, B., Previs, S. F., et al. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 96

Effects of Statins on Triglyceride Metabolism

Ginsberg, H. N. (1998) · The American Journal of Cardiology

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 96

Evolution of the Lipid Trial Protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial

Ginsberg, H. N., Bonds, D. E., Lovato, L. C., Crouse, J. R., Elam, M. B., Linz, P. E., O’Connor, P. J., Leiter, L. A., Weiss, D., Lipkin, E., et al. (2007) · The American Journal of Cardiology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 95

Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: pooled analysis of alirocumab phase 3 trials

Ray, K. K., Vallejo-Vaz, A. J., Ginsberg, H. N., Davidson, M. H., Louie, M. J., Bujas-Bobanovic, M., Minini, P., Eckel, R. H., & Cannon, C. P. (2019) · Atherosclerosis

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 69

Hypertriglyceridemia—causes, significance, and approaches to therapy

Santos-Baez, L. S., & Ginsberg, H. N. (2020) · Frontiers in Endocrinology

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 66

Engineering Liver Microtissues for Disease Modeling and Regenerative Medicine

Huang, D. (., Gibeley, S. B., Xu, C., Xiao, Y., Celik, O., Ginsberg, H. N., & Leong, K. W. (2020) · Advanced Functional Materials

3D Printing in Biomedical ResearchTissue Engineering and Regenerative Medicine

Cited by 65

Nonstatin Low-Density Lipoprotein–Lowering Therapy and Cardiovascular Risk Reduction—Statement From ATVB Council

Hegele, R. A., Gidding, S. S., Ginsberg, H. N., McPherson, R., Raal, F. J., Rader, D. J., Robinson, J. G., & Welty, F. K. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 63

Efficacy and Safety of K-877 (Pemafibrate), a Selective PPARα Modulator, in European Patients on Statin Therapy

Ginsberg, H. N., Hounslow, N. J., Senko, Y., Suganami, H., Bogdanski, P., Ceska, R., Kalina, A., Libis, R. A., Supryadkina, T. V., & Hovingh, G. K. (2022) · Diabetes Care

Lipoproteins and Cardiovascular HealthPeroxisome Proliferator-Activated Receptors

Cited by 48

Changes in lipoprotein kinetics during therapy with fenofibrate and other fibric acid derivatives

Ginsberg, H. N. (1987) · The American Journal of Medicine

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 32

γ-secretase inhibition lowers plasma triglyceride-rich lipoproteins by stabilizing the LDL receptor

Kim, K., Goldberg, I. J., Graham, M. J., Sundaram, M., Bertaggia, E., Lee, S. X., Qiang, L., Haeusler, R. A., Metzger, D., Chambon, P., et al. (2018) · Cell Metabolism

Cholesterol and Lipid MetabolismLipid metabolism and disorders

Cited by 26

Basic and translational evidence supporting the role of TM6SF2 in VLDL metabolism

Liu, J., Ginsberg, H. N., & Reyes-Soffer, G. (2024) · Current Opinion in Lipidology

Lipid metabolism and disordersCholesterol and Lipid Metabolism

Cited by 19

TM6SF2 Determines Both the Degree of Lipidation and the Number of VLDL Particles Secreted by the Liver

Reyes-Soffer, G., Liu, J., Thomas, T., Matveyenko, A., Seid, H., Ramakrishnan, R., Holleran, S., Zaghloul, N., Sztalryd-Woodle, C., Pollin, T., et al. (2023) · medRxiv

Lipid metabolism and disordersCholesterol and Lipid Metabolism

Cited by 6